Report of Foreign Issuer (6-k)
May 14 2013 - 5:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
May 14, 2013
|
|
Commission File Number: 001-35766
|
XYRATEX LTD
(Translation of registrants name into English)
Langstone Road
Havant
PO9 1SA
United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or 40-F. Form 20-F
x
Form 40-F
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)
o
|
*** Exercise
Your Right to Vote *** Important Notice Regarding the Availability of Proxy
Materials for the Shareholder Meeting to Be Held on June 26, 2013. Meeting
Information XYRATEX LTD Meeting Type: Annual Meeting For holders as of: May
2, 2013 Date: June 26, 2013 Time: 2:00 PM Local Time Location: Latham &
Watkins 885 Third Avenue New York, NY 10022-4834 USA XYRATEX LTD ATTN:
MALCOLM RULE LANGSTONE ROAD HAVANT HAMPSHIRE PO9 1SA UNITED KINGDOM You are
receiving this communication because you hold shares in the company named
above. This is not a ballot. You cannot use this notice to vote these shares.
This communication presents only an overview of the more complete proxy
materials that are available to you on the Internet. You may view the proxy
materials online at www.proxyvote.com or easily request a paper copy (see
reverse side). We encourage you to access and review all of the important
information contained in the proxy materials before voting. M60724-P40578 See
the reverse side of this notice to obtain proxy materials and voting
instructions.
|
|
Before You Vote
How to Access the Proxy Materials Proxy Materials Available to VIEW or
RECEIVE: Proxy Materials Available to VIEW or RECEIVE: NOTICE AND PROXY
STATEMENT FORM 20-F How to View Online: Have the information that is printed
in the box marked by the arrow (located on the following page) and visit:
www.proxyvote.com. How to Request and Receive a PAPER or E-MAIL Copy: If you
want to receive a paper or e-mail copy of these documents, you must request
one. There is NO charge for requesting a copy. Please choose one of the
following methods to make your request: 1) BY INTERNET: www.proxyvote.com 2)
BY TELEPHONE: 1-800-579-1639 3) BY E-MAIL*: sendmaterial@proxyvote.com * If
requesting materials by e-mail, please send a blank e-mail with the
information that is printed in the box marked by the arrow (located on the
following page) in the subject line. . XXXX XXXX XXXX . XXXX XXXX XXXX
Requests, instructions and other inquiries sent to this e-mail address will
NOT be forwarded to your investment advisor. Please make the request as
instructed above on or before June 12, 2013 to facilitate timely delivery.
M60725-P40578 How To Vote Please Choose One of the Following Voting Methods
Vote In Person: Many shareholder meetings have attendance requirements
including, but not limited to, the possession of an attendance ticket issued
by the entity holding the meeting. Please check the meeting materials for any
special requirements for meeting attendance. At the meeting, you will need to
request a ballot to vote these shares. Vote By Internet: To vote now by
Internet, go to www.proxyvote.com. Have the information that is printed in
the box marked by the arrow (located on the following page) available and
follow the instructions. Vote By Mail: You can vote by mail by requesting a
paper copy of the materials, which will include a proxy card. . XXXX XXXX
XXXX
|
|
Voting Items
The Board of Directors recommends you vote FOR the following proposals: 1.
Election of Directors Nominees: 1a. Vadim Perelman 1b. Ernest Sampias 1c. Dr.
Mike Windram The Board of Directors recommends you vote FOR the following
proposal: 2. Re-appointment of PricewaterhouseCoopers LLP as the independent
registered public accounting firm of Xyratex Ltd for its fiscal year ending
November 30, 2013 and to authorize the Audit Committee of the Board of
Directors to agree to the remuneration of the independent registered public
accounting firm. NOTE: To consider such other business as may properly come
before the meeting or any adjournment thereof. M60726-P40578
|
|
M60727-P40578
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
XYRATEX LTD
|
|
|
(Registrant)
|
|
|
|
Date: May 14, 2013
|
By:
|
/s/ Richard Pearce
|
|
|
|
|
|
Name: Richard Pearce
|
|
|
Title: Chief Financial Officer
|
XORTX Therapeutics (NASDAQ:XRTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
XORTX Therapeutics (NASDAQ:XRTX)
Historical Stock Chart
From Jul 2023 to Jul 2024